Cayston Kit
NDC 61958-0901
Product Information
Cayston (aztreonam) is a NDA-approved product labeled by Gilead Sciences, Inc.. This medication is used to treat people with a certain inherited condition (cystic fibrosis) who have a persistent lung infection with a certain bacteria (Pseudomonas aeruginosa). It is supplied as a white kit. This product entry covers the primary NDC 61958-0901 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 61958-0901?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- AZTREONAM (UNII: G2B4VE5GH8)
- AZTREONAM (UNII: G2B4VE5GH8) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LYSINE MONOHYDRATE (UNII: F7625B974U)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 901610 - aztreonam 75 MG/ML Inhalation Solution
- RxCUI: 901614 - Cayston 75 MG/ML Inhalation Solution
- RxCUI: 901614 - aztreonam 75 MG/ML Inhalation Solution [Cayston]
* Please review the full disclaimer at the bottom of this page.